Advocated for increased funding for NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated against any reductions to indirect cost reimbursement rates provided by NIH.
Duration: July 1, 2006
to
December 25, 2017
General Issues: Budget/Appropriations , Medicare/Medicaid , Medical/Disease Research/Clinical Labs , Health Issues , Immigration
Spending: about $1,350,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2006: U.S. Senate, House of Representatives, White House Office, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), U.S. Agency for International Development (USAID), Y
Y
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2017
The Petrizzo Group, Inc. terminated an engagement in which they represented Fred Hutchinson Cancer Research Center on Dec. 29, 2017.
Original Filing: 300920852.xml
Lobbying Issues
Advocated for increased funding for NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated against any reductions to indirect cost reimbursement rates provided by NIH.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Budget/Appropriations Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
3rd Quarter, 2017
In Q3, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $50,000. The report was filed on Oct. 16, 2017.
Original Filing: 300904147.xml
Lobbying Issues
Advocated for increased funding for NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated against any reductions to indirect cost reimbursement rates provided by NIH.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Budget/Appropriations Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
2nd Quarter, 2017
In Q2, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $50,000. The report was filed on July 13, 2017.
Original Filing: 300884186.xml
Lobbying Issues
Advocated for increased funding for NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated against any reductions to indirect cost reimbursement rates provided by NIH.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Budget/Appropriations Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
1st Quarter, 2017
In Q1, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $50,000. The report was filed on April 10, 2017.
Original Filing: 300863719.xml
Lobbying Issues
Advocated for increased funding for NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated against any reductions to indirect cost reimbursement rates provided by NIH.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Budget/Appropriations Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
4th Quarter, 2016
In Q4, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $50,000. The report was filed on Jan. 14, 2017.
Original Filing: 300846340.xml
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms and in favor of legislation to promote medical innovation. Advocated in favor of National Cancer Moonshot Initiative.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms and in favor of legislation to promote medical innovation. Advocated in favor of National Cancer Moonshot Initiative.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms and in favor of legislation to promote medical innovation. Advocated in favor of National Cancer Moonshot Initiative. Advocated for improvements to FDA approval process. Advocated in favor of standardized electronic medical records.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Advocated for improvements to FDA approval process. Advocated in favor of standardized electronic medical records.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
3rd Quarter, 2016
In Q3, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $50,000. The report was filed on Oct. 14, 2016.
Original Filing: 300828064.xml
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms and in favor of legislation to promote medical innovation. Advocated in favor of National Cancer Moonshot Initiative.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms and in favor of legislation to promote medical innovation. Advocated in favor of National Cancer Moonshot Initiative.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms and in favor of legislation to promote medical innovation. Advocated in favor of National Cancer Moonshot Initiative. Advocated for improvements to FDA approval process. Advocated in favor of standardized electronic medical records.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Advocated for improvements to FDA approval process. Advocated in favor of standardized electronic medical records.
2nd Quarter, 2016
In Q2, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $50,000. The report was filed on July 12, 2016.
Original Filing: 300808332.xml
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms and in favor of legislation to promote medical innovation. Advocated in favor of National Cancer Moonshot Initiative.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms and in favor of legislation to promote medical innovation. Advocated in favor of National Cancer Moonshot Initiative.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms and in favor of legislation to promote medical innovation. Advocated in favor of National Cancer Moonshot Initiative.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2016
In Q1, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $50,000. The report was filed on April 19, 2016.
Original Filing: 300794355.xml
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated on behalf of current law designation and payment for dedicated cancer centers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Type of Issue
Budget/Appropriations Medicare/Medicaid Medical/Disease Research/Clinical Labs
4th Quarter, 2015
In Q4, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $50,000. The report was filed on Jan. 15, 2016.
Original Filing: 300773369.xml
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for collaboration between the federal government and HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated against lowering NIH researcher salary cap. Advocated on behalf of current law designation and payment for dedicated cancer centers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Type of Issue
Budget/Appropriations Medicare/Medicaid
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for collaboration between the federal government and HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer. Health Insurance issues. 21st Century Cures Act. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated against lowering NIH researcher salary cap.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2015
In Q3, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $50,000. The report was filed on Oct. 19, 2015.
Original Filing: 300756637.xml
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for collaboration between the federal government and HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer. Health Insurance issues. 21st Century Cures Act. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated against lowering NIH researcher salary cap.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Type of Issue
Budget/Appropriations Medicare/Medicaid Medical/Disease Research/Clinical Labs
2nd Quarter, 2015
In Q2, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $50,000. The report was filed on July 19, 2015.
Original Filing: 300740267.xml
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for collaboration between the federal government and HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer. Health Insurance issues. 21st Century Cures Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for collaboration between the federal government and HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2015
In Q1, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $50,000. The report was filed on April 15, 2015.
Original Filing: 300715658.xml
Lobbying Issues
Advocated for funding of NIH and NCI. Advocated for collaboration between the federal government and HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Budget/Appropriations Medicare/Medicaid
4th Quarter, 2014
In Q4, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on Jan. 21, 2015.
Original Filing: 300708400.xml
Lobbying Issues
Advocated for funding of NIH, NCI. Advocated for collaboration between the federal government and HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Budget/Appropriations Medicare/Medicaid
3rd Quarter, 2014
In Q3, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on Oct. 18, 2014.
Original Filing: 300682053.xml
Lobbying Issues
Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI). Advocated for collaboration between the federal government and HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI). Advocated for collaboration between the federal government and the HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2014
In Q2, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on July 14, 2014.
Original Filing: 300656092.xml
Lobbying Issues
Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI).
Advocated for collaboration between the federal government and HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI).
Advocated for collaboration between the federal government and the HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2014
In Q1, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $20,000. The report was filed on April 15, 2014.
Original Filing: 300636549.xml
Lobbying Issues
Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI).
Advocated for collaboration between the federal government and HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI).
Advocated for collaboration between the federal government and the HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2013
In Q4, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on Jan. 7, 2014.
Original Filing: 300611839.xml
Lobbying Issues
Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI) for FY 2014 Funding.
Advocated for collaboration between the federal government and HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI) for FY 2014 Funding.
Advocated for collaboration between the federal government and the HICOR to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2013
In Q3, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on Oct. 2, 2013.
Original Filing: 300590521.xml
Lobbying Issues
Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI) for FY 2014 Funding.
Advocated for collaboration between the federal government and the Institute for Cancer Outcomes Research and Evaluation to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Budget/Appropriations Medical/Disease Research/Clinical Labs
2nd Quarter, 2013
In Q2, PETRIZZO BOND, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on July 14, 2013.
Original Filing: 300571697.xml
Lobbying Issues
Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI) for FY 2014 Funding.
Advocated for collaboration between the federal government and the Institute for Cancer Outcomes Research and Evaluation to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Budget/Appropriations Medical/Disease Research/Clinical Labs
1st Quarter, 2013
In Q1, PETRIZZO BOND, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on April 19, 2013.
Original Filing: 300555405.xml
Lobbying Issues
Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI) for FY 2013 and FY 2014 Funding.
Advocated for collaboration between the federal government and the Institute for Cancer Outcomes Research and Evaluation to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Budget/Appropriations Medical/Disease Research/Clinical Labs
4th Quarter, 2012
In Q4, PETRIZZO BOND, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $20,000. The report was filed on Jan. 21, 2013.
Original Filing: 300537424.xml
Lobbying Issues
Advocated for funding for the National Institutes of Health and National Cancer Institute for FY 2013 funding.
Advanced potential collaboration between the federal government and the Institute for Cancer Outcomes Research and Evaluation to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Budget/Appropriations Medical/Disease Research/Clinical Labs
3rd Quarter, 2012
In Q3, PETRIZZO BOND, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $20,000. The report was filed on Oct. 17, 2012.
Original Filing: 300509285.xml
Lobbying Issues
-Advocated for funding for the National Institutes of Health and National Cancer Institute for FY 2013 funding.
-Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Budget/Appropriations Medical/Disease Research/Clinical Labs
2nd Quarter, 2012
In Q2, PETRIZZO BOND, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $20,000. The report was filed on July 12, 2012.
Original Filing: 300482748.xml
Lobbying Issues
Advocated for funding for the National Institutes of Health and National Cancer Institute for FY 2013 funding.
Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Budget/Appropriations Medical/Disease Research/Clinical Labs
1st Quarter, 2012
In Q1, PETRIZZO BOND, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $20,000. The report was filed on April 11, 2012.
Original Filing: 300459108.xml
Lobbying Issues
Advocated for funding for the National Institutes of Health and National Cancer Institute for FY 2013 funding
Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases
Advocated for support of House Dear Colleague Letter asking for signatures for additional NIH Funding
Opposed H.R. 3699, which prohibits a federal agency from adopting, maintaining, continuing, or otherwise engaging in any policy, program, or other activity that: (1)causes, permits, or authorizes network dissemination of any private-sector research work without the prior consent of the publisher; or (2) requires that any actual or prospective author, or the author's employer, assent to such network dissemination.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocated for funding for the National Institutes of Health and National Cancer Institute for FY 2013 funding
Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases
Advocated for support of House Dear Colleague Letter asking for signatures for additional NIH Funding
Opposed H.R. 3699, which prohibits a federal agency from adopting, maintaining, continuing, or otherwise engaging in any policy, program, or other activity that: (1)causes, permits, or authorizes network dissemination of any private-sector research work without the prior consent of the publisher; or (2) requires that any actual or prospective author, or the author's employer, assent to such network dissemination.
Organized Fred Hutchinson Cancer Research Center (FHCRC) event demonstrating the importance of the work FHCRC is doing in Washington State and the region
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2011
In Q4, The Petrizzo Group, Inc. lobbied for Fred Hutchinson Cancer Research Center , earning $20,000. The report was filed on April 10, 2014.
Original Filing: 300633877.xml
Lobbying Issues
Advocated for level funding of the NIH and NCI for FY 2011.
Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Budget/Appropriations Medical/Disease Research/Clinical Labs
4th Quarter, 2011
In Q4, PETRIZZO BOND, INC. (PETRIZZO STRATEGIC GROUP, INC.) lobbied for Fred Hutchinson Cancer Research Center , earning $20,000. The report was filed on Jan. 10, 2012.
Original Filing: 300435562.xml
Lobbying Issues
Advocated for level funding for the National Institutes of Health and National Cancer Institute for FY 2011 funding.
Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Budget/Appropriations Medical/Disease Research/Clinical Labs
3rd Quarter, 2011
In Q3, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $20,000. The report was filed on Oct. 12, 2011.
Original Filing: 300412729.xml
Lobbying Issues
Advocated for level funding for the National Institutes of Health and National Cancer Institute for FY 2011 funding.
Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocated for level funding for the National Institutes of Health and National Cancer Institute for FY 2011federal funding.
Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2011
In Q2, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $20,000. The report was filed on July 18, 2011.
Original Filing: 300394239.xml
Lobbying Issues
Advocated for level funding for the National Institutes of Health and National Cancer Institute for FY 2011 federal funding.
Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Budget/Appropriations Medical/Disease Research/Clinical Labs
1st Quarter, 2011
In Q1, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $20,000. The report was filed on April 17, 2011.
Original Filing: 300365925.xml
Lobbying Issues
Advocated for level funding for the National Institutes of Health and National Cancer Institute for FY 2011 federal funding.
Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Budget/Appropriations Medical/Disease Research/Clinical Labs
4th Quarter, 2010
In Q4, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on Jan. 14, 2011.
Original Filing: 300338054.xml
Lobbying Issues
Advocated for increased funding for the National Institutes of Health and the National Cancer Institute.
Advocated for funding in the FY 2011 Foreign Operations Appropriations bill for language supporting USAID funding for the Uganda Cancer Institute.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocated in support of the 21st Century Cancer ALERT Act (S. 717), the Stem Cell Research Advancement Act, and the Cancer Center Assistance for Renocation and Expansion Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs Health Issues
3rd Quarter, 2010
In Q3, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on Oct. 16, 2010.
Original Filing: 300314557.xml
Lobbying Issues
Advocated for increased funding for the National Institutes of Health and the National Cancer Institute.
Advocated for funding in the FY 2011 Foreign Operations Appropriations bill for language supporting USAID funding for the Uganda Cancer Institute.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocated in support of the 21st Century Cancer ALERT Act (S. 717).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs Health Issues
2nd Quarter, 2010
In Q2, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on July 17, 2010.
Original Filing: 300290356.xml
Lobbying Issues
Advocated for increased funding for the National Institutes of Health and the National Cancer Institute.
Advocated for funding in the FY 2011 Foreign Operations Appropriations bill for language supporting USAID funding for the Uganda Cancer Institute.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocated in support of the 21st Century Cancer ALERT Act (S. 717).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs Health Issues
1st Quarter, 2010
In Q1, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on April 18, 2010.
Original Filing: 300262228.xml
Lobbying Issues
Advocated for increased funding for the National Institutes of Health and the National Cancer Institute. Advocated for federal funding in the FY 2011 Foreign Operations Appropriations bill for report language supporting USAID funding for the Uganda Cancer Institute.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocated in support of the 21st Century Cancer ALERT Act (S. 717) (Access to Life-saving Early Detection, Research and Treatment). Support funding for the Federal Coordinating Council on Comparative Effectiveness Research (CER) and urge Congress to provide the Agency for Healthcare Research and Quality with the full $286 million requested by the President.). Support amendment to health reform bill that would require coverage of routine patients costs associated with clinical trial participation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocated in support of the 21st Century Cancer ALERT Act (S. 717) (Access to Life-saving Early Detection, Research and Treatment). Support funding for the Federal Coordinating Council on Comparative Effectiveness Research (CER) and urge Congress to provide the Agency for Healthcare Research and Quality with the full $286 million requested by the President.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2009
In Q4, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on Jan. 14, 2010.
Original Filing: 300231481.xml
Lobbying Issues
Advocate for increased funding for the National Institutes of Health and the National Cancer Institute. Advocate for USAID funding through Foreign Operations Appropriations bill for US-Uganda Caner Center.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocate for the following bills: HR 1189, the Colorectal Cancer Early Detection, prevention and Treatment Act; HR 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S 332 the Lung Cancer Mortality reduction Act of 2009.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocate for the following bills: HR 1189, the Colorectal Cancer Early Detection, prevention and Treatment Act; HR 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S 332 the Lung Cancer Mortality Reduction Act of 2009. Advocate proposal for training the next generation of physician-scientists in translational medicine.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2009
In Q3, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on Oct. 17, 2009.
Original Filing: 300208736.xml
Lobbying Issues
Advocate for increased funding for the National Institutes of Health and the National Cancer Institute.
Advocate for USAID funding through Foreign Operations Appropriations Bill for US-Uganda Cancer Center.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocate for the following bills: H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act; H.R. 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S. 332 the Lung Cancer Mortality Reduction Act of 2009.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocate for the following bills: H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act; H.R. 2291 to eliminate coinsurance for screening mammography and colorectal cancer screening tests; and S. 332 the Lung Cancer Mortality Reduction Act of 2009. Advocate proposal for training the next generation of physician-scientists in translational medicine.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2009
In Q2, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on July 19, 2009.
Original Filing: 300185449.xml
Lobbying Issues
Support increased funding for NIH and NCI.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advance legislation and/or Executive branch declaration to provide liability protection to entities administering the Global HVTN Clinical Trial on behalf of NIH. Support H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act. In support of nomination of Dr. Lee Hartwell to President's Council on Science & Technology. In support of H.R. 2291 to eliminate coinsurance for screening mammagraphy and colorectal cancer screening tests.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advance legislation and/or Executive branch declaration to provide liability protection to entities administering the Global HVTN Clinical Trial on behalf of NIH. Support H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act. Support increased funding of NIH and NCI.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2009
In Q1, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on April 16, 2009.
Original Filing: 300149862.xml
Lobbying Issues
Advance legislation and/or Executive branch declaration to provide liability protection for entities administering the Global HVTN Clinical Trial on behalf of NIH. Support funding for NIH and NCI. Oppose proposals to impose new limitations on tax deductibility for contributions to charitiable organizations. Support H.R. 1189, The Colorectal Cancer Early Detection, Prevention and Treatment Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Budget/Appropriations Health Issues
Lobbying Issues
Advance legislation and/or Executive branch declaration to provide liability protection for entities administering the Global HVTN Clinical Trial on behalf of NIH. Support funding for NIH and NCI. Oppose proposals to impose new limitations on tax deductibility for contributions to charitiable organizations. Support H.R. 1189, The Colorectal Cancer Early Detection, Prevention and Treatment Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2008
In Q4, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on Jan. 19, 2009.
Original Filing: 300127257.xml
Lobbying Issues
Advance legislation and/or Executive branch declaration to provide liability protection for entities adminstering the Global HVTN Clinical Trial. Support funding for NIH, TEFRA reform legislation, and funding for Uganda Cancer Institute.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) U.S. Agency for International Development (USAID)
Type of Issue
Budget/Appropriations Medical/Disease Research/Clinical Labs
Lobbying Issues
Advance legislation and/or Executive branch declaration to provide liability protection for entities adminstering the Global HVTN Clinical Trial. Support funding for NIH, TEFRA reform legislation, and funding for Uganda Cancer Institute.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2008
In Q3, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on Oct. 18, 2008.
Original Filing: 300100111.xml
Lobbying Issues
Advance legislation and/or Executive branch declaration to provide liability protections for entities administering the Global HVTN Clinical Trial. Support funding for NIH , TEFRA Reform legislation and funding for USAID for the Uganda Cancer Institute. Support for the Access to Cancer Clincial Trials Act, HR 2676/S.2999 which would require health insurance plans to provide coverage for individuals participating in approved cancer clinical trials.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) U.S. Agency for International Development (USAID)
Lobbying Issues
Advance legislation and/or Executive branch declaration to provide liability protections for entities administering the Global HVTN Clinical Trial. Support funding for NIH , TEFRA Reform legislation and funding for USAID for the Uganda Cancer Institute. Support for the Access to Cancer Clincial Trials Act, HR 2676/S.2999, which would require health insurance plans to provide coverage for individuals participating in approved cancer clinical trials.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) U.S. Agency for International Development (USAID)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
2nd Quarter, 2008
PETRIZZO STRATEGIC GROUP, INC. amended a lobbying report for representation of Fred Hutchinson Cancer Research Center in Q22008 on Nov. 2, 2008.
Original Filing: 300110970.xml
Lobbying Issues
Federal funding for Proton Beam Therapy Center; Advance legislation and/or Executive branch declaration to provide liability protections for entities administering the Global HVTN Clinical Trial. Advance enactment of the Colon Screening Act , support funding for NIH and TEFRA Reform legislation, and funding for USAID Uganda Cancer Institute.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) U.S. Agency for International Development (USAID)
Type of Issue
Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs
2nd Quarter, 2008
In Q2, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on July 15, 2008.
Original Filing: 300065415.xml
Lobbying Issues
Federal funding for Proton Beam Therapy Center; Advance legislation and/or Executive branch declaration to provide liability protections for entities administering the Global HVTN Clinical Trial. Advance enactment of the Colon Screening Act, support funding for NIH and TEFRA Reform legislation, and funding for USAID Uganda Cancer Institute.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) U.S. Agency for International Development (USAID)
Type of Issue
Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs
1st Quarter, 2008
In Q1, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $30,000. The report was filed on April 18, 2008.
Original Filing: 300045979.xml
Lobbying Issues
Federal Funding for Proton Beam Therapy Center; Advance legislation and/or Executive branch declaration to provide liability protections for entities administering the Global HVTN Clinical Trial. Advance enactment of the Colon Screening Act, and; support increased funding for NIH and TEFRA Reform legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Type of Issue
Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs
0th Quarter, 2007
In MM, PETRIZZO STRATEGIC GROUP, INC. lobbied for Fred Hutchinson Cancer Research Center , earning $60,000. The report was filed on Aug. 6, 2007.
Original Filing: 200046947.xml
Lobbying Issues
Federal Appropriations for Proton Beam Therapy Center
Increased Funding for NIH/NCI
Lobbying Issues
Federal Appropriations for Proton Beam Therapy Center; Increased Funding for NIH/NCI; Legislation to provide for liability protections for institutions managing the global HVTN Clinical Trials Program; Reauthorization of TEFRA Legislation; Cancer Clinical Trials Act; Cancer Center Infrastructure Improvement Program; increased limits on health care visa's.
Lobbying Issues
Federal Appropriations for Proton Beam Therapy Center; Increased Funding for NIH/NCI; Legislation to provide for liability protections for institutions managing the global HVTN Clinical Trials Program; Reauthorization of TEFRA Legislation; Cancer Clinical Trials Act; Cancer Center Infrastructure Improvement Program
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2006
Petrizzo Strategic Group, Inc. filed a lobbying registration on July 29, 2006 to represent Fred Hutchinson Cancer Research Center, effective July 1, 2006.
Original Filing: 100028953.xml
Issue(s) they said they’d lobby about: Federal appropriations for mobile mammography unit for underserved areas of the PNW
Legislation to continue and expand H1-B visa program
Maintain federal recognition of "dedicated cancer centers" as under current law
Increased funding for NIH/NCI. Legislation to provide for protections for institutions managing and individuals participating in HVTN .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate